Overview

Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental Disorders

Status:
Completed
Trial end date:
2018-07-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy on sleep latency with electronic sleep diaries and the safety of NPC-15.
Phase:
Phase 3
Details
Lead Sponsor:
Nobelpharma
Treatments:
Melatonin